7/4/2025Legend Initiates First-in-Human Trial for LUCAR-G19 in Autoimmune Dise...

7/3/2025AbbVie's Venclexta Approved in China for Second-Line Treatment of del1...

7/3/2025Eli Lilly's Tirzepatide Approved in China for Treatment of Obstructive...

7/3/2025Hengrui Medicine Gains NMPA Approval for Novel Dry Eye Treatment SHR80...

7/3/2025CTTQ's Homegrown rFVIIa Wins NMPA Approval for Bleeding Disorders

7/3/2025Belief BioMed Unveils 4-Year Follow-Up Data for Hemophilia B Gene Ther...

7/3/2025Akeso Launches Clinical Trials for First Bispecific ADC

7/3/2025Dizal's Lung Cancer Pill Gains FDA Nod, Challenging Rivals in EGFR Exo...

7/2/2025HanchorBio and Henlius Ink Major Licensing Deal for I/O Candidate HCB1...

7/2/2025InventisBio Launches First Phase III Trial of TYK2 Inhibitor D‑2570 i...

7/2/2025Betta's Tibremciclib Approved in China for Advanced HR+/HER2– Breast ...

7/2/2025NMPA Grants Marketing Approval to GeneScience's Firsekibart for Acute ...

7/2/2025China Grants Conditional Approval to Bebetter Medicine's Ifupinostat f...

7/2/2025Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...

7/2/2025Biokin's Iza-bren Achieves Primary Endpoint in Phase III Trial for Nas...

7/1/2025Hengrui's Ivarmacitinib Approved in China for Severe Alopecia Areata

7/1/2025Hutchmed Receives Chinese Approval for Lung Cancer Drug Combo, Trigger...

6/30/2025QL Biopharma's Dual GLP‑1/FGF21 Agonist ZT‑003 Gains IND Nod in U.S....

6/30/2025Pfizer China's Emblaveo Cleared by NMPA for Tough Gram‑Negative Infec...

6/30/2025Cutia's Topical Finasteride Spray CU‑40102 Approved in China for Hair...

6/30/2025CTTQ's Anlotinib Wins Approval in China for First-Line Treatment of Ad...

6/28/2025I-Mab Unveils Encouraging Givastomig Results in First-Line Gastric Can...

6/27/2025Theravance Partner Viatris Lands NMPA Approval for YUPELRI, Unlocking ...

6/27/2025CARsgen Submits NDA for Satri‑cel, Poised to Be First CAR‑T for Soli...

6/24/2025IASO Bio Highlights CAR-T MS Study Results at EAN 2025

6/24/2025BrightGene Reports Strong Phase 2 Results for Dual Agonist BGM0504 and...

6/24/2025Aclaris Launches Phase 1a/1b Study of ATI-052

6/23/2025Sciwind's Ecnoglutide Achieves 15.4% Weight Loss in Chinese Obesity Ph...

6/20/2025MindRank's Oral GLP-1RA MDR-001 Achieves Promising Phase IIb Results i...

6/20/2025Simcere Gains Approval to Market Insomnia Drug Quviviq in China

Page:1/16 Total number of articles:463: [First][<<] [1] [2] [3] [4] [5] [>>] [End]